Timothy P. Noyes, CHIEF EXECUTIVE OFFICER at Aerovate Therapeutics, Inc. (AVTE), sold 30,000 shares at $19.77 ($582K) on 2023-04-03, disclosed to the SEC on 2023-04-05.
Open-market sale of $582k AVTE by CHIEF EXECUTIVE OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.16 | 9,172 | $176K | 30.2% |
| 2 | $19.16 | 9,172 | $176K | 30.2% |
| 3 | $19.77 | 5,828 | $115K | 19.8% |
| 4 | $19.77 | 5,828 | $115K | 19.8% |
| Total | $19.40 avg | 30,000 | $582K | 100% |
| Filing → |
| AVTE | SELL | 2024-04-18 | $494K | — | Filing → |
| AVTE | SELL | 2024-04-03 | $519K | — | Filing → |
| AVTE | SELL | 2023-11-03 | $11K | — | Filing → |